What you need to know

About Lymphoma

Whether you or someone you love is newly diagnosed or a long-term survivor, Lymphoma Research Foundation (LRF) is here to help you. On this website, you will find up-to-date information on the many subtypes of two closely related cancers that affect the lymphatic system- Hodgkin lymphoma and non-Hodgkin lymphoma. Teleconferences, webcasts/podcasts and written material provide you with information developed specifically for patients and loved ones by leading lymphoma experts. LRF provides in-person patient education programs around the country, offers comprehensive patient support and clinical trials services and funds lymphoma research.

We Need Your Help More Than Ever!
Your ongoing support of our research initiatives, which are so critical to helping us find a cure, and patient programs is needed more than ever before.

Foundation News: Programs, Research & Advocacy

Team LRF raises over $102,000 and counting!
On Sunday, May 3, 2009 our riders in the 2009 TD Bank Five Boro Bike Tour surpassed our fundraising goal and enjoyed a 42 mile ride through NYC.

New Hodgkin Lymphoma Resources Now Available
Three new resources are now available for people diagnosed with Hodgkin lymphoma (HL).  These include a video podcast specifically created for newly diagnosed HL patients in their 20s and 30s, a fact sheet for those with relapsed or refractory HL at any age and a comprehensive teleconference on HL that was recorded in April 2009.

Chicago Lymphoma Workshop
The Chicago Lymphoma Workshop is the premier patient education and networking forum in the region. Register Today!

LRF Advocacy: Support the Access to Cancer Clinical Trials Act of 2009
To learn more about this important federal legislation, click here.

Click for more Foundation News

Lymphoma in the News:

New RIT Method Effectively Targets and Treats T-cell non-Hodgkin lymphoma
Ajay Gopal, MD, LRF grant recipient, discovers that a novel method for delivering RIT in mantle cell lymphoma shows promise in T-cell non-Hodgkin lymphoma.

Mantle Cell Lymphoma Alert – High response rate for Lenalidomide
Thomas Habermann, MD, SAB Executive Committee member, discovers that Lenalidomide is well tolerated and active in relapsed or refractory mantle cell lymphoma patients.

Updated Non-Hodgkin Lymphoma (NHL) Guidelines
The National Comprehensive Cancer Network Announces New Guidelines for Primary Cutaneous B-Cell Lymphoma and Updated Guidelines for NHL.

Click for more Lymphoma in the News 

How You Can Make A Difference!

Join Team LRF for Lymphoma Research Foundation
Combine your enthusiasm for endurance sporting events with your dedication to raise awareness and funds for LRF!

Take a Step and Find a Cure for Lymphoma by participating in one of our 16 Lymphomathons nationwide

Click for more Make A Difference